Skip to content

Clinical trials

Colonic Neoplasms trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Colonic Neoplasms Country / region: Taiwan Clear all

39 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20032
20042
20051
20091
20101
20111
20122
20131
20142
20162
20174
20181
20204
20212
20223
20231
20243
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15
Recruiting8
Active, not recruiting7
Unknown status7
Enrolling by invitation2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Taiwan University Hospital9
Eli Lilly and Company3
Kaohsiung Medical University Chung-Ho Memorial Hospital3
Novartis Pharmaceuticals3
Chang Gung Memorial Hospital2
Dalin Tzu Chi General Hospital2
Pfizer2
Amgen1
Apollomics Inc.1
CellMaxLife1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Colonic Neoplasms39
Colorectal Neoplasms15
Rectal Neoplasms10
Carcinoma, Non-Small-Cell Lung8
Lung Neoplasms8
Neoplasms8
Intestinal Neoplasms7
Gastrointestinal Neoplasms5
Neoplasms by Site5
Thyroid Neoplasms5

Trials

Showing 26 to 39 of 39. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.